Compounds and methods for inhibiting hepatitis C viral replication
US8119592B2 · kind B2 · utility
50Cited by
60References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2006 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | Dec 23, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Macrocyclic compounds having the structures described herein are useful for inhibiting replication of the hepatitis C virus (HCV). In preferred embodiments, the compounds are active against both the NS3 protease and the NS3 helicase of HCV.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.